Skeletal muscle response to exercise training in congestive heart failure. 1990

J R Minotti, and E C Johnson, and T L Hudson, and G Zuroske, and G Murata, and E Fukushima, and T G Cagle, and T W Chick, and B M Massie, and M V Icenogle
Veterans Administration Medical Center, Albuquerque, New Mexico.

To examine the ability of the skeletal muscle of congestive heart failure (CHF) patients to adapt to chronic exercise, five patients performed localized nondominant wrist flexor training for 28 d. Inorganic phosphate (Pi) and phosphocreatine (PCr) were monitored by magnetic resonance spectroscopy in both forearms at rest and during submaximal wrist flexion exercise at 6, 12, 24, and 36 J.min-1 before and after exercise training. Simultaneous measurements of limb blood flow were made by plethysmography at 12, 24, and 36 J.min-1. Forearm muscle mass and endurance were measured by magnetic resonance imaging and wrist flexion exercise before and after training. The Pi/PCr ratio and pH were calculated from the measured Pi and PCr. Exercise cardiac output, heart rate, plasma norepinephrine, and lactate measured during training were not elevated above resting values, confirming that training was localized to the forearm flexor muscles. After training, muscle bioenergetics, as assessed by the slope of the regression line relating Pi/PCr to submaximal workloads, were improved in the trained forearm of each patient, although muscle mass, limb blood flow, and pH were unchanged. Forearm endurance increased by greater than 260% after training. In the dominant untrained forearm, none of the measured indices were affected. We conclude that localized forearm exercise training in CHF patients improves muscle energetics at submaximal workloads in the trained muscle, an effect which is independent of muscle mass, limb blood flow, or a central cardiovascular response during training. These findings indicate that peripheral muscle metabolic and functional abnormalities in CHF can be improved without altering cardiac performance.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010725 Phosphocreatine An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996) Creatine Phosphate,Neoton,Phosphocreatine, Disodium Salt,Phosphorylcreatine,Disodium Salt Phosphocreatine,Phosphate, Creatine
D012039 Regional Blood Flow The flow of BLOOD through or around an organ or region of the body. Blood Flow, Regional,Blood Flows, Regional,Flow, Regional Blood,Flows, Regional Blood,Regional Blood Flows
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac

Related Publications

J R Minotti, and E C Johnson, and T L Hudson, and G Zuroske, and G Murata, and E Fukushima, and T G Cagle, and T W Chick, and B M Massie, and M V Icenogle
December 1993, Cardiologia (Rome, Italy),
J R Minotti, and E C Johnson, and T L Hudson, and G Zuroske, and G Murata, and E Fukushima, and T G Cagle, and T W Chick, and B M Massie, and M V Icenogle
July 1997, The American journal of cardiology,
J R Minotti, and E C Johnson, and T L Hudson, and G Zuroske, and G Murata, and E Fukushima, and T G Cagle, and T W Chick, and B M Massie, and M V Icenogle
December 1991, The Journal of clinical investigation,
J R Minotti, and E C Johnson, and T L Hudson, and G Zuroske, and G Murata, and E Fukushima, and T G Cagle, and T W Chick, and B M Massie, and M V Icenogle
August 1994, Postgraduate medicine,
J R Minotti, and E C Johnson, and T L Hudson, and G Zuroske, and G Murata, and E Fukushima, and T G Cagle, and T W Chick, and B M Massie, and M V Icenogle
December 2002, Journal of cardiovascular risk,
J R Minotti, and E C Johnson, and T L Hudson, and G Zuroske, and G Murata, and E Fukushima, and T G Cagle, and T W Chick, and B M Massie, and M V Icenogle
May 1990, Clinical science (London, England : 1979),
J R Minotti, and E C Johnson, and T L Hudson, and G Zuroske, and G Murata, and E Fukushima, and T G Cagle, and T W Chick, and B M Massie, and M V Icenogle
January 1996, Journal of the American College of Cardiology,
J R Minotti, and E C Johnson, and T L Hudson, and G Zuroske, and G Murata, and E Fukushima, and T G Cagle, and T W Chick, and B M Massie, and M V Icenogle
October 1991, Circulation,
J R Minotti, and E C Johnson, and T L Hudson, and G Zuroske, and G Murata, and E Fukushima, and T G Cagle, and T W Chick, and B M Massie, and M V Icenogle
September 2002, International journal of cardiology,
J R Minotti, and E C Johnson, and T L Hudson, and G Zuroske, and G Murata, and E Fukushima, and T G Cagle, and T W Chick, and B M Massie, and M V Icenogle
April 1996, Heart (British Cardiac Society),
Copied contents to your clipboard!